MRC1 and glioma: To further demonstrate the specificity and efficacy of Mann2-DTPA-Gd to CD206+ TAMs, we performed MR imaging of glioma using Mrc1+/- mice, Mrc1-/- mice, and Mrc1+/+ mice with competition using D-mannose.